Domain-specific function of ShcC docking protein in neuroblastoma cells

Area of Science:

• Cellular signaling and cancer biology

Background:

• ShcC docking proteins act as substrates for receptor tyrosine kinases.
• Neuroblastoma cells can exhibit hyperphosphorylated ShcC complexed with anaplastic lymphoma kinase (ALK).

Purpose of the Study:

• To investigate the role of ShcC in neuroblastoma cell survival, differentiation, motility, and transformation.
• To elucidate the specific functions of ShcC's phosphotyrosine-binding and SH2 domains in cancer signaling.

Main Methods:

• Utilized mutant ShcC (3YF-ShcC) lacking Grb2-binding sites to assess pathway involvement.
• Overexpressed ShcC and its mutants in neuroblastoma cells.
• Assessed anchorage independence and in vivo tumorigenicity.
• Examined the effect of ShcC on Src family kinase phosphorylation and the Src/Fyn-Cas pathway.

Main Results:

• Mutant ShcC (3YF-ShcC) impaired NB-39-nu cell survival, differentiation, and motility by blocking ERK and Akt pathways.
• Overexpression of ShcC or 3YF-ShcC decreased anchorage independence and in vivo tumorigenicity, indicating an SH2 domain-dependent suppressive effect on transformation.
• ShcC overexpression suppressed sustained Src family kinase phosphorylation post-detachment, potentially independent of Grb2-binding sites, modulating the Src/Fyn-Cas pathway.

Conclusions:

• ShcC plays a dual role in neuroblastoma, influencing cell signaling pathways and exhibiting tumor-suppressive functions.
• Phosphotyrosine-dependent and -independent functions of ShcC, particularly through its SH2 domain, are critical in modulating neuroblastoma cell behavior and transformation.